RadNet (RDNT) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
18 May, 2026Executive summary
Achieved record first quarter revenue of $575.6 million, up 22.1% year-over-year, and adjusted EBITDA of $63.3 million, up 36.3%, despite $13M revenue and $9M EBITDA impact from severe winter weather.
Digital Health segment revenue surged 51.5% to $29.1 million, with ARR nearly doubling to $96.9 million, reflecting strong AI and informatics growth and recent acquisitions.
Imaging Center segment expanded to 435 centers, with same-center revenue up 8.9% and advanced imaging volumes now representing 29.3% of procedural volume.
Net loss attributable to common stockholders narrowed to $33.5 million, with adjusted diluted loss per share improving to $(0.28) from $(0.34) year-over-year.
Completed significant acquisitions in Florida, Indiana, and France, and expanded Digital Health with the Gleamer SAS acquisition.
Financial highlights
Imaging Center revenue reached $556.8 million (up 20.7% year-over-year); Digital Health revenue was $29.1 million (up 51.5%).
Adjusted EBITDA margin for Imaging Center segment improved by 52 basis points after weather adjustments.
Cash and equivalents at quarter-end were $455.3 million; leverage ratio (Net Debt/Adjusted EBITDA) slightly below 2.0.
Days sales outstanding (DSO) reached a record low of 29.5 days.
Cash flow from operations was $79.0 million; net cash used in investing activities was $370.97 million, mainly for acquisitions.
Outlook and guidance
2026 Imaging Center guidance raised: revenue now $2,355–$2,405 million, adjusted EBITDA $340–$353 million, free cash flow $112–$122 million.
Digital Health full-year guidance reaffirmed: $135M–$145M revenue, $10M–$12M adjusted EBITDA before non-capitalized R&D.
Over 70% of studies expected to run through clinical AI by year-end; all radiologist reports to use AI-powered summarization.
Sufficient liquidity and borrowing capacity to fund operations and future acquisitions.
Expect continued margin improvement in Digital Health as recent investments and acquisitions are integrated.
Latest events from RadNet
- $103M all-stock deal forms a global AI breast imaging leader, targeting $7M+ cost synergies.RDNT
M&A Announcement9 Jul 2026 - Record revenue and EBITDA growth, AI expansion, and acquisitions led to raised 2025 guidance.RDNT
Q3 20259 Jul 2026 - Record Q2 revenue and EBITDA, strong AI growth, and raised 2024 guidance amid cost pressures.RDNT
Q2 20248 Jul 2026 - Advanced imaging and digital health drive robust growth, with major AI and OEM partnerships announced.RDNT
Bank of America Securities 2024 Leveraged Finance Conference8 Jul 2026 - AI-powered imaging and outpatient expansion drive double-digit growth and industry leadership.RDNT
44th Annual J.P. Morgan Healthcare Conference8 Jul 2026 - Q1 revenue up 9.2%, guidance raised, and iCAD acquisition to expand AI breast health.RDNT
Q1 20258 Jul 2026 - Advanced imaging, AI, and acquisitions drive robust growth and margin expansion for 2026.RDNT
47th Annual Raymond James Institutional Investor Conference8 Jul 2026 - Record revenue, major AI acquisition, and strong 2026 growth outlook highlight the quarter.RDNT
Q4 20253 May 2026 - Annual meeting covers director elections, auditor ratification, compensation, and equity plan expansion.RDNT
Proxy filing20 Apr 2026